Clinical efficacy of Buzhong Yiqi decoction in the treatment of hospital-acquired pneumonia with multi-drug resistant bacteria: a prospective, randomized, multicenter controlled trial.

医学 肺炎 汤剂 内科学 随机对照试验 临床试验 机械通风 断奶 药物治疗
作者
Xiangru Xu,Zhou Yi,Chen Gang,Lei Ming,Zhang Wen,W U Xinxin,P U Yuting,Caiyu Chen,Sun Yuting,Shuang Zhou,Bangjiang Fang
出处
期刊:PubMed Central [National Institutes of Health]
卷期号:43 (5): 1010-1018 被引量:4
标识
DOI:10.19852/j.cnki.jtcm.20230713.002
摘要

OBJECTIVE: To evaluate the efficacy and safety of Buzhong Yiqi decoction (, BZYQ) in the treatment of hospital-acquired pneumonia (HAP) with multi-drug-resistant bacteria (MDRB). METHODS: This 28-day study was conducted at 5 clinical centers in Shanghai. The eligible patients were randomly assigned (1:1) into the intervention group (BZYQ plus conventional Western Medicine therapy) and control group (conventional Western Medicine therapy). The primary outcomes were the clinical response, clinical pulmonary infection score (CPIS), and microbiologic response. The secondary outcomes were the 28-day all-cause mortality (ACM), Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) score, ventilator weaning rate, length of mechanical ventilation (MV), length of hospital stay, and changes of infection indicators. RESULTS: Altogether 83 subjects in the intervention group and 85 subjects in the control group were analyzed. The clinical success rate (48.2%) and the pathogen eradication rate (59.0%) of the intervention group were all better than those of the control group (32.9% and 38.9%, respectively) with statistically significant differences (<0.05). The CPIS score of the intervention group (8.9 ± 1.7) was lower than that of the control group (9.6 ± 2.5) (<0.05). The length of MV in the intervention group [(13.7 ± 6.4) d] was significantly shorter than that of the control group [ (17.2 ± 7.2) d] (<0.05). The 28-day ACM of the intervention group (13.33%) was lower than that of the control group (21.2%) with no statistically significant difference (>0.05). The differences between two groups in ventilator weaning rate, length of hospital stay, and APACHE Ⅱ score were not statistically significant (> 0.05). The intervention group displayed decreases in white blood cell count, C-reactive protein, neutrophil percentage, and procalcitonin at day 28 compared with baseline (<0.05). No serious adverse events occurred in either group during the 28-day follow-up. CONCLUSION: BZYQ may be an effective therapeutic option for the management of HAP with MDRB.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
深情安青的应助被niubi666采纳,获得10
2秒前
2秒前
小黑发布了新的文献求助10
2秒前
小蘑菇的应助被soni采纳,获得10
3秒前
3秒前
鬼豆完成签到,获得积分10
4秒前
4秒前
shuyiWang发布了新的文献求助10
4秒前
4秒前
搜集达人的应助被恭敬采纳,获得10
5秒前
5秒前
null的应助被冉ran11采纳,获得10
5秒前
Echo完成签到,获得积分10
5秒前
嘻嘻关注了科研通微信公众号
6秒前
思源的应助被正直的蚂蚁采纳,获得10
7秒前
7秒前
7秒前
东方天奇完成签到 ,获得积分10
7秒前
Kunpeng的应助被养只缅因采纳,获得10
7秒前
9秒前
9秒前
努力TOP发布了新的文献求助20
10秒前
10秒前
暮离发布了新的文献求助10
10秒前
张星星发布了新的文献求助10
11秒前
大橙子发布了新的文献求助10
11秒前
科研通AI6.2的应助被和谐含蕾采纳,获得10
11秒前
999完成签到 ,获得积分10
11秒前
刘晨飞发布了新的文献求助10
11秒前
李爱国的应助被正直的蚂蚁采纳,获得10
12秒前
汉堡包的应助被陆羽采纳,获得10
12秒前
星辰大海的应助被HHH采纳,获得10
12秒前
穆梦山完成签到,获得积分10
12秒前
jjyy发布了新的文献求助10
12秒前
灵巧菠萝发布了新的文献求助10
13秒前
HYD完成签到,获得积分10
13秒前
十六完成签到,获得积分20
13秒前
小橘猫发布了新的文献求助20
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163746
求助须知:如何正确求助?哪些是违规求助? 9557874
关于积分的说明 21742203
捐赠科研通 7754407
什么是DOI,文献DOI怎么找? 3428345
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472945